Skip to main content
. 2022 May 6;10(2):e001541. doi: 10.1136/fmch-2021-001541

Figure 2.

Figure 2

Side effects reported at follow-up. (A) Post-treatment pain at follow-up, grouped by timing of follow-up visit. (B) Post-treatment bleeding at follow-up, grouped by timing of follow-up visit. (C) Post-treatment vaginal discharge at follow-up, grouped by timing of follow-up visit. ES, estimate.